Prime Therapeutics Newsroom

GradientRule_withspacer

Prime Therapeutics launches Specialty Monitor™ to deliver total drug management insights

Industry leading analytics tool maximizes power of both medical, pharmacy benefits data, provides clients actionable savings opportunities as use of specialty drugs grow. Press release

GradientRule_withspacer

News from Prime

Prime Therapeutics responds to safe harbor proposed rule on prescription drug rebates

Prime released a statement from Mike Kolar, its senior vice president and general counsel, in response to the Health and Human Services (HHS) Office of Inspector General’s new safe harbor rule proposal to eliminate prescription drug rebates in Medicare Part D.


Prime expert discusses orphan disease treatments at Market Access Summit

Rae McMahan addressed critical cost and care challenges for payers and patients.


Prime Therapeutics hires Sid Sahni to lead enterprise strategy, corporate development

Sid brings more than 20 years of experience in health care and pharmacy benefits management to Prime.


 

 

 

 

 

 

 

 

 

 

 

 

 

GradientRule_withspacer

Prime Insights

Explore drug research, analyses and insights from Prime's pharmacy experts.

Prime Insights

Get in touch

Connect with one of our media experts to learn more about the latest news and trends in the pharmacy benefit management industry.

Email the newsroom team
Sign-up for regular email updates

      Facebook